Omnitram Pharmacokinetic and Analgesic Study Following CY2D6 Inhibition With Paroxetine In Healthy Volunteers

NCT03312777 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: Omnitram
DRUG: Tramadol
DRUG: Placebo

Sponsor

Syntrix Biosystems, Inc.

Collaborators

[object Object]
[object Object]
[object Object]